(Q39255929)

English

A bio-nanocapsule containing envelope protein domain III of Japanese encephalitis virus protects mice against lethal Japanese encephalitis virus infection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

A bio-nanocapsule containing envelope protein domain III of Japanese encephalitis virus protects mice against lethal Japanese encephalitis virus infection (English)

1 reference

Europe PubMed Central

10 September 2017

Japanese encephalitis virus

0 references

Japanese encephalitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Takeshi Miyata

1

1 reference

Europe PubMed Central

10 September 2017

Senji Tafuku

2

1 reference

Europe PubMed Central

10 September 2017

Tetsuya Harakuni

3

1 reference

Europe PubMed Central

10 September 2017

Masayuki Tadano

4

1 reference

Europe PubMed Central

10 September 2017

Nobuo Yoshimoto

5

1 reference

Europe PubMed Central

10 September 2017

Masumi Iijima

6

1 reference

Europe PubMed Central

10 September 2017

Hidenori Matsuo

7

1 reference

Europe PubMed Central

10 September 2017

Goro Matsuzaki

8

1 reference

Europe PubMed Central

10 September 2017

Shun'ichi Kuroda

9

1 reference

Europe PubMed Central

10 September 2017

Takeshi Arakawa

10

1 reference

Europe PubMed Central

10 September 2017

publication date

1 June 2013

1 reference

Europe PubMed Central

10 September 2017

Microbiology and Immunology

1 reference

Europe PubMed Central

10 September 2017

57

1 reference

Europe PubMed Central

10 September 2017

6

1 reference

Europe PubMed Central

10 September 2017

470-477

1 reference

Europe PubMed Central

10 September 2017

Virus-like particles as immunogens

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

The coming of age of virus-like particle vaccines

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Virus-like particles: passport to immune recognition

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Exploiting viral properties for the rational design of modern vaccines

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

A role for lipid rafts in B cell antigen receptor signaling and antigen targeting

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Molecular Mechanisms of B Cell Antigen Receptor Trafficking

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

B-cell antigen-receptor signalling in lymphocyte development

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Dendritic cell-independent B cell activation during acute virus infection: a role for early CCR7-driven B-T helper cell collaboration

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Development of bionanocapsules targeting brain tumors.

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Specific protein delivery to target cells by antibody-displaying bionanocapsules

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Japanese encephalitis virus structural and nonstructural proteins expressed in Escherichia coli induce protective immunity in mice

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Tricomponent immunopotentiating system as a novel molecular design strategy for malaria vaccine development

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Adjuvants: no longer a 'dirty little secret', but essential key players in vaccines of the future.

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Nanocapsules incorporating IgG Fc-binding domain derived from Staphylococcus aureus protein A for displaying IgGs on immunosensor chips.

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Effects of protein aggregates: an immunologic perspective

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12055

21 January 2018

Identifiers

10.1111/1348-0421.12055

1 reference

Europe PubMed Central

10 September 2017

1 reference

Europe PubMed Central

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39255929&oldid=1816048504"